News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,472 Results
Type
Article (2396)
Company Profile (45)
Press Release (35031)
Section
Business (14101)
Career Advice (76)
Deals (2073)
Drug Delivery (8)
Drug Development (4086)
Employer Resources (10)
FDA (428)
Job Trends (759)
News (20099)
Policy (1051)
Tag
Academia (143)
Alliances (3458)
Alzheimer's disease (41)
Antibody-drug conjugate (ADC) (8)
Approvals (430)
Bankruptcy (11)
Best Places to Work (473)
Biosimilars (9)
Biotechnology (34)
Breast cancer (14)
Cancer (90)
Career advice (64)
CAR-T (8)
Cell therapy (25)
Clinical research (3109)
Collaboration (57)
Compensation (29)
COVID-19 (179)
C-suite (16)
Data (64)
Diabetes (7)
Diagnostics (458)
Earnings (4138)
Employer resources (8)
Events (5870)
Executive appointments (52)
FDA (457)
Funding (49)
Gene editing (10)
Gene therapy (7)
GLP-1 (56)
Government (146)
Healthcare (705)
Infectious disease (182)
Inflammatory bowel disease (10)
Intellectual property (8)
IPO (977)
Job creations (289)
Job search strategy (62)
Layoffs (34)
Legal (210)
Lung cancer (13)
Manufacturing (14)
Medical device (304)
Medtech (304)
Mergers & acquisitions (1134)
Metabolic disorders (20)
Neuroscience (70)
NextGen Class of 2024 (350)
Non-profit (153)
Northern California (246)
Opinion (13)
Patents (12)
People (5551)
Phase I (1337)
Phase II (1569)
Phase III (832)
Pipeline (33)
Postmarket research (30)
Preclinical (581)
Radiopharmaceuticals (11)
Rare diseases (11)
Real estate (419)
Regulatory (780)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (8)
Series A (11)
Southern California (233)
Startups (485)
United States (1151)
Vaccines (22)
Weight loss (7)
Date
Last 7 days (10)
Last 30 days (114)
Last 365 days (2565)
2025 (5)
2024 (2619)
2023 (2861)
2022 (3756)
2021 (4053)
2020 (3471)
2019 (2062)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1372)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (42)
Arizona (13)
Asia (1831)
Australia (293)
California (546)
Canada (103)
China (27)
Colorado (11)
Connecticut (9)
Europe (3771)
Florida (30)
Illinois (12)
Indiana (22)
Kansas (12)
Maryland (19)
Massachusetts (190)
Minnesota (13)
New Jersey (32)
New York (32)
North Carolina (75)
Northern California (246)
Ohio (20)
Pennsylvania (24)
South America (40)
Southern California (233)
Texas (44)
Washington State (32)
37,472 Results for "vigene biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Charles River Laboratories Completes Acquisition of Vigene Biosciences
Charles River Laboratories International, Inc. announced that it has completed the previously announced acquisition of Vigene Biosciences, Inc. for $292.5 million in cash, subject to customary closing adjustments.
June 29, 2021
·
4 min read
Press Releases
Solid Biosciences Added to the Nasdaq Biotechnology Index
December 24, 2024
·
1 min read
Press Releases
OraSure Technologies Acquires Sherlock Biosciences
December 20, 2024
·
9 min read
Press Releases
Ensysce Biosciences Regains Full Compliance with Nasdaq
December 23, 2024
·
3 min read
Press Releases
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
November 21, 2024
·
1 min read
Layoffs
Aadi Bioscience to Lay Off 80% of R&D Staff
Aadi Bioscience expects that pipeline adjustments and the workforce reduction will extend its cash runway into at least the second half of 2026.
August 21, 2024
·
1 min read
·
Angela Gabriel
Press Releases
HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT
December 4, 2024
·
1 min read
Press Releases
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
December 24, 2024
·
5 min read
Press Releases
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
October 15, 2024
·
5 min read
Press Releases
HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
December 19, 2024
·
1 min read
1 of 3,748
Next
